OncoMatch/Clinical Trials/NCT05842044
NSAID Use After Robotic Partial Nephrectomy
Is NCT05842044 recruiting? Yes, currently enrolling (May 2026). This Phase 2 trial studies multiple treatments including Ketorolac and Oxycodone for kidney cancer.
Treatment: Ketorolac · Acetaminophen · Oxycodone · Hydromorphone · Ibuprofen — The purpose of this study is to see how effective non-steroidal anti-inflammatory drugs (NSAIDs) are at controlling pain without side effects in participants after robotic-assisted partial nephrectomy.
Check if I qualifyExtracted eligibility criteria
Cancer type
Renal Cell Carcinoma
Lab requirements
Kidney function
Glomerular filtration rate (GFR) < 60 mL/min/1.73m2 (Modification of Diet in Renal Disease (MDRD) equation) [excluded]
Cardiac function
Myocardial infarction or unstable angina within 12 months; any history of coronary artery bypass graft surgery [excluded]
Myocardial infarction or unstable angina within 12 months. Any history of coronary artery bypass graft surgery. Glomerular filtration rate (GFR) < 60 mL/min/1.73m2 (Modification of Diet in Renal Disease (MDRD) equation).
Structured fields extracted by AI. May contain errors — verify against the official protocol.
US trial sites
- University of Miami · Miami, Florida
Showing up to 5 US sites. See all sites on ClinicalTrials.gov →
Could you qualify for this trial?
Enter your biomarker results to see how this trial's eligibility criteria match your specific cancer profile.
Check if I qualify